NanoViricides, Inc. (NNVC)

NanoViricides Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	8.15	14.07	20.52	13.71	2.56
Cash & Cash Equivalents	8.15	14.07	20.52	13.71	2.56
Cash Growth	-42.06%	-31.44%	49.66%	436.50%	-63.92%
Other Current Assets	0.3	0.35	0.31	0.28	0.27
Total Current Assets	8.45	14.42	20.82	13.99	2.83
Property, Plant & Equipment	8.11	8.69	9.08	9.54	10.23
Goodwill and Intangibles	0.35	0.38	0.35	0.37	0.39
Other Long-Term Assets	0	0	0	0.02	0
Total Long-Term Assets	8.45	9.08	9.44	9.93	10.62
Total Assets	16.9	23.49	30.26	23.91	13.45
Accounts Payable	0.39	0.27	0.23	0.94	1.13
Current Debt	0	0.09	0.1	1.14	0
Other Current Liabilities	0.14	0.05	0.02	0.07	1.71
Total Current Liabilities	0.53	0.41	0.35	2.16	2.85
Other Long-Term Liabilities	1.5	0	0	0	0
Total Long-Term Liabilities	1.5	0	0	0	0
Total Liabilities	2.03	0.41	0.35	2.16	2.85
Total Debt	0	0.09	0.1	1.14	0
Debt Growth	-	-0.54%	-91.68%	-	-
Retained Earnings	-131.08	-122.49	-114.39	-105.56	-92.12
Shareholders' Equity	14.87	23.08	29.91	21.76	10.6
Net Cash / Debt	8.15	13.97	20.42	12.56	2.56
Net Cash / Debt Growth	-41.67%	-31.58%	62.54%	391.69%	-63.92%
Net Cash Per Share	0.70	1.21	1.87	2.24	0.71
Working Capital	7.91	14	20.47	11.83	-0.02
Book Value Per Share	1.28	2.00	2.74	3.87	2.95

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).